Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late add-on pegylated interferon alpha-2a to ongoing nucleos(t)ide therapy in chronic hepatitis B
2014-000815-15Phase 2Active
- Sponsor
- Luigi Sacco University Hospital
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Luigi Sacco University Hospital. Primary endpoint: Loss of HBsAg and/or HBeAg. Started Dec 2014; status: active.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2014-000815-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000815-15.